Metformin has been tested in clinical trials on DMD patients in combination with L-Arginine or L-Citrulline, an L-arginine precursor, to evaluate whether stimulation of AMPK and NO pathways are able to synergistically improve dystrophic muscle metabolism. The gene discussed is PRKAA1; the disease is Duchenne muscular dystrophy.